Impact of intrauterine growth restriction on long-term health

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 3, 2014, Pages 249-254

  Salam, Rehana A ^a   Das, Jai K ^a   Bhutta, Zulfiqar A ^a,b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

catch up growth; intrauterine growth restriction; metabolic diseases; prenatal programming

Indexed keywords

ADULTHOOD; CARDIOVASCULAR DISEASE; COMPLICATION; DELIVERY; FETAL WELL BEING; FETUS DISTRESS; HEALTH; HUMAN; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; METABOLIC SYNDROME X; NEWBORN MORBIDITY; NEWBORN MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRENATAL CARE; REVIEW; RISK FACTOR; SYSTOLIC HYPERTENSION; ECHOGRAPHY; FEMALE; FETAL GROWTH RETARDATION; FETUS DEVELOPMENT; FETUS ECHOGRAPHY; HEALTH STATUS; PATHOPHYSIOLOGY; PREGNANCY;

FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HEALTH STATUS; HUMANS; PREGNANCY; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84898547149     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000051     Document Type: Review

References (60)

1. Rosenberg A, editor. The IUGR newborn. Seminars in perinatology. Philadelphia, PA, USA: Elsevier; 2008.
2. Mandruzzato G, Antsaklis A, Botet F, et al. Intrauterine restriction (IUGR). J Perinat Med 2008; 36:277-281.
3. Longo S, Bollani L, Decembrino L, et al. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med 2013; 26:222-225.
4. Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol 2008; 32:274-280.
5. Roberts DJ, Post MD. The placenta in preeclampsia and intrauterine growth restriction. J Clin Pathol 2008; 61:1254-1260.
6. Von Beckerath A-K, Kollmann M, Rotky-Fast C, et al. Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction. Am J Obstet Gynecol 2012; 208:130-136.
7. Srinivas SK, Edlow AG, Neff PM, et al. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J Perinatol 2009; 29:680-684.
8. Salam RA, Das JK, Ali A, et al. Maternal undernutrition and intrauterine growth restriction. Expert Rev Obstet Gynecol 2013; 8:559-567.
9. Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382:427-451.
10. Sukrat B, Wilasrusmee C, Siribumrungwong B, et al. Hemoglobin concentration and pregnancy outcomes: a systematic review and meta-analysis. Biomed Res Int 2013; 2013:1-9.
11. Suhag A, Berghella V. Intrauterine growth restriction (IUGR): etiology and diagnosis. Curr Obstet Gynecol Rep 2013; 2:1-10.
12. Arcangeli T, Thilaganathan B, Hooper R, et al. Neurodevelopmental delay in small babies at term: a systematic review. Ultrasound Obstet Gynecol 2012; 40:267-275.
13. Baschat AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 2011; 37:501-514.
14. Smith G, Fretts RC. Stillbirth. Lancet 2007; 370:1715-1725.
15. Dessi A, Ottonello G, Fanos V. Physiopathology of intrauterine growth retardation: from classic data to metabolomics. J Matern Fetal Neonatal Med 2012; 25:13-18.
16. Chan PYL, Morris JM, Leslie GI, et al. The long-term effects of prematurity and intrauterine growth restriction on cardiovascular, renal, and metabolic function. Int J Pediatr 2010; 2010:1-10.
17. Zanardo V, Visentin S, Trevisanuto D, et al. Fetal aortic wall thickness: a marker of hypertension in IUGR children & quest. Hypertens Res 2013; 35:440-443.
18. Bjarnegard N, Morsing E, Cinthio M, et al. Cardiovascular function in adulthood following intrauterine growth restriction with abnormal fetal blood flow. Ultrasound Obstet Gynecol 2013; 41:177-184.
19. Geva R, Eshel R, Leitner Y, et al. Neuropsychological outcome of children with intrauterine growth restriction: a 9-year prospective study. Pediatrics 2006; 118:91-100.
20. Wojcik W, Lee W, Colman I, et al. Foetal origins of depression? A systematic review and meta-analysis of low birth weight and later depression. Psychol Med 2013; 43:1-12.
21. Abitbol CL, Rodriguez MM. The long-term renal and cardiovascular consequences of prematurity. Nat Rev Nephrol 2012; 8:265-274.
22. Bacchetta J, Harambat J, Dubourg L, et al. Both extrauterine and intrauterine growth restriction impair renal function in children born very preterm. Kidney Int 2009; 76:445-452.
23. Schreuder M, Pierik LJ, van Dael KW. Clinical course of pediatric IgA nephropathy is influenced by intrauterine growth restriction. Safety in glomerular numbers: consequences of intrauterine growth restriction on renal morphology, function and disease. Haarlem: Febodruk; 2006. pp. 112-117.
24. Teeninga N, Schreuder MF, Bokenkamp A, et al. Influence of low birth weight on minimal change nephrotic syndrome in children, including a meta-analysis. Nephrol Dial Transplant 2008; 23:1615-1620.
25. Bacchetta J, Cochat P. Both extrauterine and intrauterine growth restriction impair renal function in children born very preterm. Arch Pediatr 2008; 15:1212-1222.
26. Long term respiratory consequences of intrauterine growth restriction. in: Pike K, Jane Pillow J, Lucas JS, editors. Seminars in fetal and neonatal medicine. Philadelphia, PA, USA: Elsevier; 2012
27. Kallen B, Finnstra O, Nygren K-G, Olausson PO. Association between preterm birth and intrauterine growth retardation and child asthma. Eur Respir J 2013; 41:671-676.
28. Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol 2009; 160:337-347.
29. Crume TL, Scherzinger A, Stamm E, et al. The Long term impact of intrauterine growth restriction in a diverse US cohort of children: The EPOCH study. Obesity 2013; 22:608-615.
30. Neitzke U, Harder T, Schellong K, et al. Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: a critical appraisal of the experimental evidence. Placenta 2008; 29:246-254.
31. Fowden AL, Giussani DA, Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 2005; 81:723-734.
32. Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction 2004; 127:515-526.
33. Phillips DI. Fetal growth and programming of the hypothalamic- pituitaryadrenal axis. Clin Exp Pharmacol Physiol 2001; 28:967-970.
34. Gatford KL, Simmons RA. Prenatal programming of insulin secretion in intrauterine growth restriction. Clin Obstet Gynecol 2013; 56:520-528.
35. Ong KK, Dunger DB. Birth weight, infant growth and insulin resistance. Eur J Endocrinol 2004; 151 (Suppl 3):U131-U139.
36. Saenger P, Czernichow P, Hughes I, Reiter EO. Small for gestational age: short stature and beyond. Endocr Rev 2007; 28:219-251.
37. Tinnion R, Gillone J, Cheetham T, Embleton N. Preterm birth and subsequent insulin sensitivity: a systematic review. Arch Dis Child; 2013. [Epub ahead of print]. doi:10.1136/archdischild-2013-304615
38. Ibanez L, Lopez-Bermejo A, Suarez L, et al. Visceral adiposity without overweight in children born small for gestational age. J Clin Endocrinol Metab 2008; 93:2079-2083.
39. Jaquet D, Deghmoun S, Chevenne D, et al. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia 2005; 48:849-855.
40. Yajnik CS, Lubree HG, Rege SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 2002; 87:5575-5580.
41. Boiko J, Jaquet D, Chevenne D, et al. In situ lipolytic regulation in subjects born small for gestational age. Int J Obes (Lond) 2005; 29:565-570.
42. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 2000; 85:1401-1406.
43. Gerhardt A, Howe N, Kru ssel JS, et al. Elevated lipoprotein (a) levels and homozygous human platelet antigen 1b (HPA-1b) genotype are risk factors for intrauterine growth restriction (IUGR). J Thromb Thrombolysis 2013; 37:107-117.
44. Javaid MK, Godfrey KM, Taylor P, et al. Umbilical cord leptin predicts neonatal bone mass. Calcif Tissue Int 2005; 76:341-347.
45. McMillen IC, Muhlhausler BS, Duffield JA, Yuen BS. Prenatal programming of postnatal obesity: fetal nutrition and the regulation of leptin synthesis and secretion before birth. Proc Nutr Soc 2004; 63:405-412.
46. Yuen BS, Owens PC, Muhlhausler BS, et al. Leptin alters the structural and functional characteristics of adipose tissue before birth. FASEB J 2003; 17:1102-1104.
47. Koklu E, Ozturk MA, Kurtoglu S, et al. Aortic intima-media thickness, serum IGF-I, IGFBP-3, and leptin levels in intrauterine growth-restricted newborns of healthy mothers. Pediatr Res 2007; 62:704-709.
48. Martinez-Cordero C, Amador-Licona N, Guizar-Mendoza JM, et al. Body fat at birth and cord blood levels of insulin, adiponectin, leptin, and insulin-like growth factor-I in small-for-gestational-age infants. Arch Med Res 2006; 37:490-494.
49. Valuniene M, Verkauskiene R, Boguszewski M, et al. Leptin levels at birth and in early postnatal life in small- and appropriate-for-gestational-age infants. Medicina (Kaunas) 2007; 43:784-791.
50. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85:571-633.
51. Stocker CJ, Arch JR, Cawthorne MA. Fetal origins of insulin resistance and obesity. Proc Nutr Soc 2005; 64:143-151.
52. Cianfarani S, Agostoni C, Bedogni G, et al. Effect of intrauterine growth retardation on liver and long-term metabolic risk. Int J Obes 2012; 36:1270- 1277.
53. Lopez-Bermejo A. Insulin resistance after prenatal growth restriction: is it mediated by adiponectin deficiency? Clin Endocrinol (Oxf) 2006; 64:479- 480.
54. Mandruzzato G, Antsaklis A, Botet F, et al. Intrauterine restriction (IUGR). J Perinat Med 2008; 36:277-281.
55. Imdad A, Yakoob MY, Siddiqui S, Bhutta Z. Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduction of IUGR related stillbirths. BMC Public Health 2011; 11 (Suppl 3):S1-S12.
56. Singh S, Verma U, Shrivastava K, et al. Role of color doppler in the diagnosis of intra uterine growth restriction (IUGR). Int J Reprod Contracept Obstet Gynecol 2013; 2:566-572.
57. Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and metaanalysis. BJOG 2013; 120:681-694.
58. Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005; 25:258-264.
59. Grivell R, Dodd J, Robinson J. The prevention and treatment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009; 23:795- 807.
60. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3:CD004454.